Transforming Cancer Care with Cell-Free DNA Testing

Program Committee Moderator(s)

• 

  Arivarasan Karunamurthy

  Assistant Professor
  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania, United States

Description: Cell-free DNA (cfDNA) testing is at the forefront of cancer diagnostics and disease monitoring, providing a non-invasive method to detect genetic mutations, track tumor dynamics, and assess treatment responses. This session will delve into the latest advancements in cfDNA testing for both blood-based and non-blood-based samples, showcasing its applications in personalized medicine. We will examine the current applications, adoption challenges, and future directions of cfDNA testing, highlighting its profound impact on enhancing patient outcomes and facilitating more precise, targeted therapies.

Presentations:

• 10:15 AM - 11:00 AM EST

  Beyond the Blood: Unlocking the Potential of Non-Blood-Based Cell-Free DNA in Cancer Care
  

  Breakout Speaker: Christina Lockwood, PhD – University of Washington Medical Center
• 11:00 AM - 11:45 AM EST

  Revolutionizing Oncology: Advancements and Impact of Cell-Free DNA Testing in Precision Cancer Care
  

  Breakout Speaker: Trevor Pugh, PhD, FACMG (he/him/his) – Princess Margaret Cancer Centre / Ontario Institute for Cancer Research